Stephen G Spiro

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi request reprint Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition)
    Stephen G Spiro
    Department of Respiratory Medicine, University College Hospital, Grafton Way, London WC1E 6AU, UK
    Chest 132:149S-160S. 2007
  2. ncbi request reprint Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes
    Michael A Beckles
    Department of Respiratory Medicine, Royal Free Hospital, London, UK
    Chest 123:97S-104S. 2003
  3. ncbi request reprint The physiologic evaluation of patients with lung cancer being considered for resectional surgery
    Michael A Beckles
    Department of Respiratory Medicine, Royal Free Hospital, London, UK
    Chest 123:105S-114S. 2003
  4. ncbi request reprint Small cell lung cancer: treatment review
    Samantha Cooper
    Department of Thoracic Medicine, University College Hospital, London, UK
    Respirology 11:241-8. 2006
  5. ncbi request reprint Ensuring the right PET scan for the right patient
    Stephen G Spiro
    Department of Respiratory Medicine, University College Hospital, UCLH NHS Foundation Trust, London WC1E 6AU, United Kingdom
    Lung Cancer 59:48-56. 2008
  6. ncbi request reprint Lung cancer--where are we today? Current advances in staging and nonsurgical treatment
    Stephen G Spiro
    Department of Respiratory Medicine, University College, London Hospitals National Health Service Trust, United Kingdom
    Am J Respir Crit Care Med 166:1166-96. 2002
  7. doi request reprint Complications of lung cancer treatment
    Stephen G Spiro
    Department of Respiratory Medicine, University College London Hospitals, London, United Kingdom
    Semin Respir Crit Care Med 29:302-17. 2008
  8. doi request reprint Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
    Jean Pierre Pignon
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    J Clin Oncol 26:3552-9. 2008
  9. pmc Screening for lung cancer: yet another problem
    Stephen G Spiro
    Thorax 62:105-6. 2007
  10. ncbi request reprint Esophageal endoscopic ultrasound/endobronchial ultrasound-guided fine needle aspiration: a new dawn for the respiratory physician?
    Sam M Janes
    Am J Respir Crit Care Med 175:297-9. 2007

Collaborators

Detail Information

Publications15

  1. ncbi request reprint Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes: ACCP evidenced-based clinical practice guidelines (2nd edition)
    Stephen G Spiro
    Department of Respiratory Medicine, University College Hospital, Grafton Way, London WC1E 6AU, UK
    Chest 132:149S-160S. 2007
    ..This chapter of the guidelines is intended to provide an evidence-based assessment of the initial evaluation of patients recognized as having lung cancer and the recognition of paraneoplastic syndromes...
  2. ncbi request reprint Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes
    Michael A Beckles
    Department of Respiratory Medicine, Royal Free Hospital, London, UK
    Chest 123:97S-104S. 2003
    ..Also described are the common features of the various paraneoplastic syndromes associated with lung cancer...
  3. ncbi request reprint The physiologic evaluation of patients with lung cancer being considered for resectional surgery
    Michael A Beckles
    Department of Respiratory Medicine, Royal Free Hospital, London, UK
    Chest 123:105S-114S. 2003
    ..Combining LVRS and lung cancer resection should probably be limited to those patients with heterogeneous emphysema, particularly emphysema limited to the lobe containing the tumor...
  4. ncbi request reprint Small cell lung cancer: treatment review
    Samantha Cooper
    Department of Thoracic Medicine, University College Hospital, London, UK
    Respirology 11:241-8. 2006
    ....
  5. ncbi request reprint Ensuring the right PET scan for the right patient
    Stephen G Spiro
    Department of Respiratory Medicine, University College Hospital, UCLH NHS Foundation Trust, London WC1E 6AU, United Kingdom
    Lung Cancer 59:48-56. 2008
    ..In conclusion, PET scanning has the potential to improve the diagnosis and management of lung cancer for many patients. Further studies and refinement of guidelines and procedures will maximise the benefit of this important technique...
  6. ncbi request reprint Lung cancer--where are we today? Current advances in staging and nonsurgical treatment
    Stephen G Spiro
    Department of Respiratory Medicine, University College, London Hospitals National Health Service Trust, United Kingdom
    Am J Respir Crit Care Med 166:1166-96. 2002
    ..Novel therapies are urgently needed for all cell types of lung cancer...
  7. doi request reprint Complications of lung cancer treatment
    Stephen G Spiro
    Department of Respiratory Medicine, University College London Hospitals, London, United Kingdom
    Semin Respir Crit Care Med 29:302-17. 2008
    ..Even during palliative care great attention has to be taken to minimize side effects of commonly used medications...
  8. doi request reprint Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group
    Jean Pierre Pignon
    Institut Gustave Roussy, 39 rue Camille Desmoulins, 94805 Villejuif, France
    J Clin Oncol 26:3552-9. 2008
    ..The aim of the Lung Adjuvant Cisplatin Evaluation was to identify treatment options associated with a higher benefit or groups of patients who particularly benefit from postoperative chemotherapy...
  9. pmc Screening for lung cancer: yet another problem
    Stephen G Spiro
    Thorax 62:105-6. 2007
  10. ncbi request reprint Esophageal endoscopic ultrasound/endobronchial ultrasound-guided fine needle aspiration: a new dawn for the respiratory physician?
    Sam M Janes
    Am J Respir Crit Care Med 175:297-9. 2007
  11. ncbi request reprint Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis
    Stephen G Spiro
    University College Hospitals Trust, London, United Kingdom
    J Clin Oncol 24:3823-30. 2006
    ..To replicate an earlier National Cancer Institute of Canada (NCIC) trial that examined the effect on survival of the timing of thoracic radiotherapy (TRT) in patients with limited disease small-cell lung cancer (SCLC)...
  12. ncbi request reprint One hundred years of lung cancer
    Stephen G Spiro
    Department of Thoracic Medicine, Middlesex Hospital, Mortimer Street, London WIT 3AA, UK
    Am J Respir Crit Care Med 172:523-9. 2005
    ..The most important and cost-effective management for lung cancer is smoking cessation, but for those with the disease, novel agents and treatment approaches are urgently needed...
  13. ncbi request reprint The treatment of advanced non-small cell lung cancer
    Stephen G Spiro
    Department of Thoracic Medicine, University College Hospitals NHS Trust, The Middlesex Hospital, London, UK
    Curr Opin Pulm Med 11:287-91. 2005
    ..In particular, it reviews the recommendations for chemotherapy in the elderly and for those with a poor performance status. The role of the newer growth factor-inhibiting agents is also discussed...
  14. ncbi request reprint Management of patients with COPD
    Frank McCaughan
    Lancet 364:2015. 2004
  15. doi request reprint Lung cancer staging with minimally invasive endoscopic techniques
    Neal Navani
    JAMA 299:2509; author reply 2510-1. 2008